Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-12 Sale | 2024-12-12 8:02 pm | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $22.11 | $19,899 | 38,781 (Direct) | View |
| 2024-09-12 Sale | 2024-09-12 5:19 pm | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $21.23 | $19,104 | 39,681 (Direct) | View |
| 2024-06-12 Sale | 2024-06-12 9:40 pm | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $24.16 | $21,740 | 40,581 (Direct) | View |
| 2024-03-12 Sale | 2024-03-12 9:33 pm | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $26.44 | $23,792 | 41,481 (Direct) | View |
| 2023-06-13 Sale | 2023-06-13 8:54 pm | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 9,000 | $1.6572 | $14,915 | 460,936 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-04 Option Award | 2025-06-06 06:27 am | N/A 2035-06-04 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 5:31 pm | N/A 2035-02-13 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-12 8:02 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $7.1 | 38,781 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-12 8:02 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $0 | 38,781 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-12 5:19 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $7.1 | 39,681 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-12 5:19 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $0 | 39,681 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-12 9:40 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $7.1 | 40,581 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-12 9:40 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $0 | 40,581 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-12 9:33 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $7.1 | 41,481 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-12 9:33 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 900 | $0 | 41,481 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 7:31 pm | N/A 2034-02-15 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-10-12 Tax Withholding | 2023-10-13 6:58 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh Chief Operating Officer | 37,126 | $0.85 | 250,097 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-13 8:54 pm | N/A 2030-05-31 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 9,000 | $0 | 460,936 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-13 8:54 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 9,000 | $0.71 | 460,936 (Direct) | View |
| 2023-04-12 Tax Withholding | 2023-04-14 4:16 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 37,126 | $1.46 | 287,223 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-20 6:00 pm | N/A 2033-03-17 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:02 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 214,722 | $0 | 324,349 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-08 4:01 pm | N/A 2032-04-07 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks | 48,441 | $0 | 48,441 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:02 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh COO,CFO and CS | 94,772 | $0 | 94,772 (Direct) | View |
Ownership | 2021-10-01 4:09 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See remarks | 0 | $0 | 292,340 (Direct) | View |